BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38347513)

  • 21. Epidemiology and comorbidity of hidradenitis suppurativa in Korea for 17 years: A nationwide population-based cohort study.
    Lee JW; Heo YW; Lee JH; Lee S
    J Dermatol; 2023 Jun; 50(6):778-786. PubMed ID: 36806098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study.
    Kim G; Jang SY; Nam CM; Kang ES
    J Hepatol; 2018 Mar; 68(3):476-484. PubMed ID: 29107150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The risk trajectory of different cardiovascular morbidities associated with chronic kidney disease among patients with newly diagnosed diabetes mellitus: a propensity score-matched cohort analysis.
    Chao CT; Lee SY; Wang J; Chien KL; Hung KY
    Cardiovasc Diabetol; 2021 Apr; 20(1):86. PubMed ID: 33894776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Separate and joint effects of diabetes mellitus and chronic kidney disease on the risk of acute coronary syndrome: a population-based cohort study.
    Chang YT; Liu CC; Tsai LM; Li CY; Sung JM
    Medicine (Baltimore); 2014 Dec; 93(28):e261. PubMed ID: 25526451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and Impact of Preexisting Comorbidities on Overall Clinical Outcomes of Hospitalized COVID-19 Patients.
    Koyyada R; Nagalla B; Tummala A; Singh AD; Patnam S; Barigala R; Kandala M; Krishna V; Manda SV
    Biomed Res Int; 2022; 2022():2349890. PubMed ID: 35402606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends and risk factors of elderly-onset Crohn's disease: A nationwide cohort study.
    Moon JM; Kang EA; Han K; Hong SW; Soh H; Park S; Lee J; Lee HJ; Im JP; Kim JS
    World J Gastroenterol; 2020 Jan; 26(4):404-415. PubMed ID: 32063689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute kidney disease is common and associated with poor outcomes in patients with cirrhosis and acute kidney injury.
    Patidar KR; Naved MA; Grama A; Adibuzzaman M; Aziz Ali A; Slaven JE; Desai AP; Ghabril MS; Nephew L; Chalasani N; Orman ES
    J Hepatol; 2022 Jul; 77(1):108-115. PubMed ID: 35217065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of chronic kidney disease in patients with kidney stones-a nationwide cohort study.
    Chuang TF; Hung HC; Li SF; Lee MW; Pai JY; Hung CT
    BMC Nephrol; 2020 Jul; 21(1):292. PubMed ID: 32698782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Favorable clinical outcome of nonalcoholic liver cirrhosis patients with coronary artery disease: A population-based study.
    Tsai MC; Yang TW; Wang CC; Wang YT; Sung WW; Tseng MH; Lin CC
    World J Gastroenterol; 2018 Aug; 24(31):3547-3555. PubMed ID: 30131661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impacts of chronic kidney disease and diabetes on cardiovascular mortality in a general Japanese population: A 20-year follow-up of the NIPPON DATA90 study.
    Hirata A; Okamura T; Sugiyama D; Kuwabara K; Kadota A; Fujiyoshi A; Miura K; Okuda N; Ohkubo T; Okayama A; Ueshima H;
    Eur J Prev Cardiol; 2017 Mar; 24(5):505-513. PubMed ID: 27856810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urate-lowering Therapy and Chronic Kidney Disease Development in Patients with Gout.
    Yen FS; Wei JC; Chang CL; Yang CC; Hsu CC; Hwu CM
    Int J Med Sci; 2021; 18(12):2599-2606. PubMed ID: 34104091
    [No Abstract]   [Full Text] [Related]  

  • 32. Comorbidity-stratified estimates of 30-day mortality risk by age for unvaccinated men and women with COVID-19: a population-based cohort study.
    Abdel-Qadir H; Austin PC; Sivaswamy A; Chu A; Wijeysundera HC; Lee DS
    BMC Public Health; 2023 Mar; 23(1):482. PubMed ID: 36915068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic kidney disease in Polish elderly population aged 75+: results of the WOBASZ Senior Survey.
    Zdrojewski Ł; Król E; Rutkowski B; Piotrowski W; Pająk A; Drygas W; Zdrojewski T
    Int Urol Nephrol; 2017 Apr; 49(4):669-676. PubMed ID: 27988911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic kidney disease in Cameroon: a scoping review.
    Aseneh JB; Kemah BA; Mabouna S; Njang ME; Ekane DSM; Agbor VN
    BMC Nephrol; 2020 Sep; 21(1):409. PubMed ID: 32967645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonapnea sleep disorders and incident chronic kidney disease: a population-based retrospective cohort study.
    Huang ST; Lin CL; Yu TM; Yang TC; Kao CH
    Medicine (Baltimore); 2015 Jan; 94(4):e429. PubMed ID: 25634175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health behaviors and risk factors associated with chronic kidney disease in Korean patients with diabetes: the Fourth Korean National Health and Nutritional Examination Survey.
    Lee SJ; Chung CW
    Asian Nurs Res (Korean Soc Nurs Sci); 2014 Mar; 8(1):8-14. PubMed ID: 25030487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk for Acromegaly-related Comorbidities by Sex in Korean Acromegaly.
    Park KH; Lee EJ; Seo GH; Ku CR
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31903478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic kidney disease and risk factor prevalence in Saint Kitts and Nevis: a cross-sectional study.
    Crews DC; Campbell KN; Liu Y; Bussue O; Dawkins I; Young BA
    BMC Nephrol; 2017 Jan; 18(1):7. PubMed ID: 28056873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between chronic kidney disease and the most common corneal ectasia disease (keratoconus): a nationwide cohort study.
    Jan RL; Weng SF; Wang JJ; Chang YS
    BMC Nephrol; 2021 Mar; 22(1):109. PubMed ID: 33765939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-utility analysis of the National Health Screening Program for chronic kidney disease in Korea.
    Go DS; Kim SH; Park J; Ryu DR; Lee HJ; Jo MW
    Nephrology (Carlton); 2019 Jan; 24(1):56-64. PubMed ID: 29206319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.